Linsitinib T6017
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
OSI-906 (Linsitinib) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell
CAS nr:
867160-71-2
Purity:
98%
Molecular Weight:
421,49
SMILES:
C[C@]1(C[C@@H](C1)c1nc(c2n1ccnc2N)c1cc2c(cc1)ccc(n2)c1ccccc1)O
Formula:
C26H23N5O
Pathway:
Tyrosine Kinase/Adaptors,Others
Target:
IGF-1R,Others
